athenahealth Inc. (NASDAQ:ATHN) – Equities researchers at SunTrust Banks issued their FY2018 EPS estimates for athenahealth in a research note issued on Wednesday. SunTrust Banks analyst S. Draper forecasts that the firm will post earnings of $1.55 per share for the year.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, October 20th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.13. The business earned $276.70 million during the quarter. athenahealth had a return on equity of 6.60% and a net margin of 1.80%. The business’s quarterly revenue was up 17.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.36 EPS.
Several other equities analysts also recently weighed in on the company. JPMorgan Chase & Co. downgraded athenahealth from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $128.00 to $111.00 in a research report on Friday. Morgan Stanley downgraded athenahealth from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $153.00 to $117.00 in a research report on Wednesday. Canaccord Genuity reiterated a “hold” rating and set a $127.00 target price on shares of athenahealth in a research report on Sunday, October 23rd. Oppenheimer Holdings Inc. set a $170.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Thursday, October 20th. Finally, Jefferies Group upped their price target on athenahealth from $105.00 to $110.00 and gave the stock an “underperform” rating in a research note on Friday, October 14th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $140.26.
Shares of athenahealth (NASDAQ:ATHN) opened at 103.01 on Friday. athenahealth has a 1-year low of $100.01 and a 1-year high of $170.42. The stock has a market cap of $4.06 billion, a PE ratio of 219.64 and a beta of 1.28. The company’s 50-day moving average price is $120.93 and its 200 day moving average price is $127.89.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Quadrant L P CA purchased a new position in athenahealth during the third quarter worth approximately $114,000. Advisor Group Inc. bought a new stake in shares of athenahealth during the second quarter valued at about $118,000. FineMark National Bank & Trust increased its stake in shares of athenahealth by 4.5% in the second quarter. FineMark National Bank & Trust now owns 944 shares of the company’s stock valued at $130,000 after buying an additional 41 shares during the period. KBC Group NV bought a new stake in shares of athenahealth during the second quarter valued at about $135,000. Finally, Societe Generale bought a new stake in shares of athenahealth during the second quarter valued at about $176,000.
In other athenahealth news, Director Brandon H. Hull sold 2,400 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $130.00, for a total transaction of $312,000.00. Following the transaction, the director now owns 3,987 shares of the company’s stock, valued at approximately $518,310. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Bradford Kyle Armbrester sold 2,545 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $130.00, for a total value of $330,850.00. The disclosure for this sale can be found here. Company insiders own 3.04% of the company’s stock.
athenahealth Company Profile